Lawson Kroeker Investment Management Continues to Hold Stake in Anheuser (BUD); Biogen (BIIB) Holder Royal London Asset Management LTD Has Lifted Its Position

Anheuser-Busch InBev SA/NV (NYSE:BUD) Logo

Royal London Asset Management Ltd increased its stake in Biogen Inc (BIIB) by 29.4% based on its latest 2018Q4 regulatory filing with the SEC. Royal London Asset Management Ltd bought 26,068 shares as the company’s stock declined 1.50% while stock markets rallied. The institutional investor held 114,736 shares of the biological products (no diagnostic substances) company at the end of 2018Q4, valued at $33.68 million, up from 88,668 at the end of the previous reported quarter. Royal London Asset Management Ltd who had been investing in Biogen Inc for a number of months, seems to be bullish on the $63.25 billion market cap company. The stock increased 0.30% or $0.96 during the last trading session, reaching $321.52. About 1.16M shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 15.91% since March 15, 2018 and is uptrending. It has outperformed by 11.54% the S&P500. Some Historical BIIB News: 13/04/2018 – Biogen likely to exercise option to raise stake in Samsung Bioepis, insiders say; 02/05/2018 – Bristol-Myers Squibb and Biogen Are the Pharmas Most Trusted by Doctors, Study Finds; 29/05/2018 – In Search for Dip Repurchasers, Goldman Points to Apple, Biogen; 05/04/2018 – $ABBV $BIIB Settlement on Humira #Biosimilar in Europe -; 07/05/2018 – Eaton Vance Worldwide Health Adds Glaxo, Cuts Biogen; 23/04/2018 – Biogen’s Tecfidera Falls After 1-Wk Rise, Avonex Declines: MS; 20/04/2018 – BIOGEN – CO, IONIS EXPANDED COLLABORATION THROUGH NEW 10-YR AGREEMENT TO DEVELOP NOVEL ANTISENSE DRUG CANDIDATES FOR RANGE OF NEUROLOGICAL DISEASES; 17/04/2018 – Biogen Builds on Its 40-Year Legacy in Neuroscience with Presentation of Research from Its Portfolio of Medicines and; 07/03/2018 – EMA – EMA’S RECOMMENDATION TO SUSPEND ZINBRYTA AND RECALL THE PRODUCT IS BEING SENT TO THE EUROPEAN COMMISSION FOR A LEGALLY BINDING DECISION; 20/04/2018 – $BIIB $IONS Interesting slide on antisense and gene therapy being “Complementary”, “Combination / sequential”. Will see if Biogen answer any question re $AVXS

Lawson Kroeker Investment Management Inc increased its stake in Anheuser (BUD) by 35.5% based on its latest 2018Q4 regulatory filing with the SEC. Lawson Kroeker Investment Management Inc bought 33,890 shares as the company’s stock rose 6.11% with the market. The institutional investor held 129,358 shares of the beverages (production and distribution) company at the end of 2018Q4, valued at $8.51M, up from 95,468 at the end of the previous reported quarter. Lawson Kroeker Investment Management Inc who had been investing in Anheuser for a number of months, seems to be bullish on the $155.19B market cap company. The stock decreased 1.34% or $1.08 during the last trading session, reaching $79.65. About 1.22M shares traded. Anheuser-Busch InBev SA/NV (NYSE:BUD) has declined 25.28% since March 15, 2018 and is downtrending. It has underperformed by 29.65% the S&P500. Some Historical BUD News: 25/04/2018 – AB INBEV CEO BRITO RESPONDS TO INVESTOR QUESTION AT AGM; 22/03/2018 – ANADOLU EFES AEFES.IS COMPANIES RECEIVE ALL REGULATORY APPROVALS IN RUSSIA AND UKRAINE AND COMPLETION IS EXPECTED IN MARCH 2018; 04/04/2018 – C&C Group In Talks With Support of AB InBev; 09/05/2018 – ANHEUSER BUSCH INBEV SAYS EXPECT TO DELIVER STRONG REVENUE AND EBITDA GROWTH IN FY18; 08/05/2018 – ANHEUSER BUSCH- UNIT EXERCISING OPTION TO REDEEM IN FULL ENTIRE OUTSTANDING PRINCIPAL AMOUNT OF FOLLOWING SERIES OF NOTES ON 6 JUNE 2018; 03/04/2018 – JSE: ANH – AB INBEV AND ANADOLU EFES COMPLETE MERGER OF BUSINESSES IN RUSSIA AND UKRAINE; 21/03/2018 – Trump supports massive U.S. funding bill, shutdown looms; 25/04/2018 – Bud brewer hopeful that aluminium tariffs won’t hit U.S. allies; 22/03/2018 – U.S. House sends $1.3 trillion spending bill to Senate as Friday deadline looms; 09/05/2018 – AB InBev 1Q Net Pft $1.44B

Investors sentiment decreased to 0.56 in Q4 2018. Its down 0.32, from 0.88 in 2018Q3. It dived, as 87 investors sold BUD shares while 151 reduced holdings. 45 funds opened positions while 88 raised stakes. 68.85 million shares or 0.53% less from 69.22 million shares in 2018Q3 were reported. Atria Invests Lc has invested 0.01% of its portfolio in Anheuser-Busch InBev SA/NV (NYSE:BUD). Ntv Asset Mgmt Ltd Com holds 0.13% or 6,200 shares. Moreover, Bridges Invest Management has 0.02% invested in Anheuser-Busch InBev SA/NV (NYSE:BUD). Redmond Asset Ltd Llc accumulated 0.18% or 5,669 shares. Gfs Advsrs Limited Liability Co reported 10,500 shares stake. Pecaut & holds 0.78% or 14,360 shares in its portfolio. Edge Wealth Mngmt Ltd Llc accumulated 100 shares. Jnba Finance has invested 0% in Anheuser-Busch InBev SA/NV (NYSE:BUD). Huntington Fincl Bank holds 0% or 1,939 shares in its portfolio. Barclays Public Ltd Com owns 116,204 shares for 0.01% of their portfolio. Mai stated it has 22,578 shares. Franklin Res invested in 0.26% or 6.48M shares. 1,475 are owned by Pittenger Anderson Inc. Td Asset holds 54,849 shares. Hightower Advisors Ltd Liability Corp owns 0.01% invested in Anheuser-Busch InBev SA/NV (NYSE:BUD) for 12,298 shares.

More notable recent Anheuser-Busch InBev SA/NV (NYSE:BUD) news were published by: Marketwatch.com which released: “Hexo shares a bright spot in weak cannabis sector as revenue jumps in latest quarter – MarketWatch” on March 14, 2019, also Finance.Yahoo.com with their article: “Tilray Stock: Time for Another Bull Run? – Yahoo Finance” published on March 13, 2019, Investorideas.com published: “Global #Water Concerns Drive Clean Water Technology: Where to Get Your H2O Next; (OTC: $WTNW) (NYSE: $BUD) (NASDAQ: $PRMW) (NASDAQ: $WTER) – InvestorIdeas.com” on March 07, 2019. More interesting news about Anheuser-Busch InBev SA/NV (NYSE:BUD) were released by: Benzinga.com and their article: “RBC To Investors: This Bud’s For You (NYSE:BUD) – Benzinga” published on October 29, 2018 as well as Benzinga.com‘s news article titled: “Earnings Scheduled For February 28, 2019 – Benzinga” with publication date: February 28, 2019.

Royal London Asset Management Ltd, which manages about $11.42 billion US Long portfolio, decreased its stake in Alkermes Plc (NASDAQ:ALKS) by 45,541 shares to 63,649 shares, valued at $1.81 million in 2018Q4, according to the filing. It also reduced its holding in Garmin Ltd (NASDAQ:GRMN) by 75,191 shares in the quarter, leaving it with 49,357 shares, and cut its stake in Everest Re Group Ltd (NYSE:RE).

Since September 26, 2018, it had 1 insider buy, and 1 sale for $20.22 million activity. Ehlers Michael D also sold $350,000 worth of Biogen Inc. (NASDAQ:BIIB) shares.

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Nasdaq.com which released: “Top Stock Reports for Visa, Honeywell & Biogen – Nasdaq” on March 12, 2019, also 247Wallst.com with their article: “Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses – 24/7 Wall St.” published on February 22, 2019, Seekingalpha.com published: “Biogen: Adding To The Pipeline – Seeking Alpha” on March 08, 2019. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Nasdaq.com and their article: “Biotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News & More – Nasdaq” published on March 06, 2019 as well as Seekingalpha.com‘s news article titled: “Biogen to buy Nightstar Therapeutics for $877M – Seeking Alpha” with publication date: March 04, 2019.

Investors sentiment decreased to 0.91 in 2018 Q4. Its down 0.10, from 1.01 in 2018Q3. It worsened, as 79 investors sold BIIB shares while 314 reduced holdings. 83 funds opened positions while 276 raised stakes. 181.17 million shares or 8.34% more from 167.21 million shares in 2018Q3 were reported. Fernwood Management Lc accumulated 8,985 shares or 1.74% of the stock. Nippon Life Invsts Americas Incorporated invested in 0.34% or 13,010 shares. Lombard Odier Asset (Europe) invested 0.06% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Mitsubishi Ufj And Bk has 178,493 shares. Pensionfund Dsm Netherlands stated it has 9,300 shares. Lau Assocs Ltd invested in 5,108 shares. Barrett Asset Management Ltd Llc has 104 shares. Everence Management holds 0.33% or 4,668 shares in its portfolio. Court Place Advsr Limited Liability Co has 15,144 shares for 2.08% of their portfolio. Kwmg Ltd Com, a Kansas-based fund reported 7 shares. Gradient Investments Limited Liability Co reported 230 shares. Ibm Retirement Fund stated it has 3,454 shares or 0.24% of all its holdings. State Board Of Administration Of Florida Retirement System invested 0.25% in Biogen Inc. (NASDAQ:BIIB). Pzena Inv Mgmt Ltd Com has invested 0% in Biogen Inc. (NASDAQ:BIIB). Eagle Asset Mngmt Inc holds 0% or 719 shares in its portfolio.

Biogen Inc. (NASDAQ:BIIB) Ratings Chart